Hopital Robert Debre - AP-HP
Paris, 75019, France
Location status: Recruiting
NCT Number: NCT07311356
The AM2P study aims to evaluate the long-term prognosis and quality of life of patients with early-onset anorexia nervosa, assessed 4 to 9 years after hospitalization. Prognosis will be determined using a composite outcome measure based on questionnaire responses and health indicators, including body mass index (BMI). In addition, the study will examine the patients' overall physical condition both at the time of assessment and during the interval between their last hospitalization and the present evaluation.
Interested in participating?
Request Info0 year–30 year
All sexes
Observational
Paris, 75019, France
Location status: Recruiting
This study includes all patients who were hospitalized at Robert Debré Hospital in Paris between 2016 and 2021 for early-onset anorexia nervosa. During follow-up interviews, participants will complete a standardized set of questionnaires assessing their mental and physical health (EDE-Q, PHQ-9, MSI-BPD, GAD-7, and SF-12). The primary outcome is the evaluation of the severity of the eating disorder, measured with the EDE-Q. Secondary outcomes will be derived from the additional questionnaires and will include body mass index (BMI), menstrual status, follow-up data, general well-being, impact of the eating disorder, hospital readmission, suicide attempts, depressive symptoms, borderline personality traits, anxiety, quality of life, educational attainment, occupational status, and treatments received. We hypothesize that approximately 50% of patients will achieve remission three years after hospitalization.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
the percentage of subjective cure
Time frame: 6 months
The number of hospitalizations related to anorexia nerovsa
Interested in participating?
Request InfoAssistance Publique - Hôpitaux de Paris
Other
Evalutation of the Prognosis and Quality of Life of Patients Hospitalized for Early-onset Anorexia Nervosa
Acronym: AM2P
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05554172
Anorexia Nervosa, Feeding and Eating Disorders
New York, United States
View Trial DetailsNCT07734779
Anorexia Nervosa, Behavior
Shanghai, China
View Trial DetailsNCT07772167
Anorexia Nervosa, Feeding and Eating Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT07169747
Anorexia Nervosa, Feeding and Eating Disorders
Lund, Sweden
View Trial Details